Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Antibiotics After FESS
NCT01919411Phase 4Completed
- Sponsor
- Massachusetts Eye and Ear
- Start
- Feb 2013
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of amoxicillin + clavulanate in chronic rhinosinusitis (CRS), sponsored by Massachusetts Eye and Ear. Started Feb 2013; status: completed.
02
Drugs
amoxicillin + clavulanate
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on NCT01919411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01919411.